15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Alvotech, 4 rate it Buy or better, 1 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $4.00 to $14.00 (about 3.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $7.80 sits 46% above the current $5.33. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 4 over recent months. On the fundamentals, the Street sees revenue growth near 12% this year and 19% next, consensus EPS building from about $0.21 next quarter toward $0.23 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy467%
Hold117%
Sell117%
Strong Sell00%
Based on 6 analysts giving stock ratings to Alvotech.
As of Sep, 4 of 6 firms rate ALVO a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
ALVO EPS & revenue forecast
EPS · NEXT QUARTER
$0.21
Range $0.16 – $0.25 · 2 analysts · +1956% YoY
Next period, 2 analysts expect Alvotech to earn $0.21 a share (range $0.16 – $0.25), versus $0.01 a year earlier. Full-year consensus is $-0.02, growing to $0.23 the year after.
REVENUE · NEXT QUARTER
$283.6M
Range $283.6M – $283.6M · 2 analysts · +52% YoY
Revenue is expected to reach $283.6M (range $283.6M – $283.6M), +52.0% year-over-year. Full-year consensus is $659.3M, rising to $775.7M next year.
Top analysts covering Alvotech
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ALVO.
#1
Jason Gerberry
B of A Securities · Rank #125
Buy
$7.00+31.5% to target
Overall win rate
46%
+ Follow
#2
GS
Glen Santangelo
Barclays
Sell
$4.00-24.9% to target
Coverage
—
+ Follow
#3
Ashwani Verma
UBS
Buy
$6.00+12.7% to target
Coverage
—
+ Follow
#4
TB
Thibault Boutherin
Morgan Stanley
Buy
$10.00+87.8% to target
Coverage
—
+ Follow
#5
Carl Byrnes
Northland Capital Markets
Buy
$10.00+87.8% to target
Coverage
—
+ Follow
ALVO stock forecast FAQ
What is ALVO's average 12-month price target?+
The 5 analysts with a live target average $7.80 for Alvotech over the next 12 months, ranging from a $14.00 high to a $4.00 low.
Is ALVO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 4 are Buy or Strong Buy, 1 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for ALVO?+
The Street-high target is $14.00 (Morgan Stanley), and the Street-low is $4.00 (Barclays). The average of all 5 active targets is $7.80.
How many Wall Street analysts cover ALVO?+
6 analysts have an active rating on Alvotech, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering ALVO?+
Among analysts who currently cover ALVO, Jason Gerberry of B of A Securities has the strongest overall Quantellect track record (Rank #125). Their current call is Buy with a $7.00 target.
What is Alvotech's projected EPS for next quarter?+
The consensus estimate is $0.21 per share (range $0.16 – $0.25) across 2 analysts. Full-year EPS is projected at $-0.02, rising to $0.23 the following year.
How much revenue is Alvotech expected to report next quarter?+
Consensus revenue is $283.6M (range $283.6M – $283.6M). Full-year revenue is projected at $659.3M, growing to $775.7M next year.
Have analysts been upgrading or downgrading ALVO lately?+
As of Sep, 4 of 6 firms rate ALVO a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ALVO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
